Laser-spectroscopic sensing device for diagnostic assessment of sinusitis

Informazioni relative al progetto

SINUSLIGHT

ID dell’accordo di sovvenzione: 790786

DOI

10.3030/790786

Progetto chiuso

Data della firma CE 1 Dicembre 2017

Data di avvio 1 Gennaio 2018

Data di completamento 30 Giugno 2018

Finanziato da

• INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology

Costo totale

€ 71 429,00

Contributo UE

€ 50 000,00

Coordinato da

GPX MEDICAL AB
Sweden

Periodic Reporting for period 1 - SINUSLIGHT (Laser-spectroscopic sensing device for diagnostic assessment of sinusitis)

Periodo di rendicontazione: 2018-01-01 al 2018-06-30

Sintesi del contesto e degli obiettivi generali del progetto

The feasibility study has comprised a market analysis and an evaluation of the technical requirements for commercialisation of a hand-held medical device for diagnostic assessment of sinusitis.

GPX Medical develops laser-based gas measuring technology with the aim of medical applications. This technology can be used for analysis of gas-filled cavities in the human body, such as the sinuses. The technology can be implemented as a hand-held instrument, based on laser spectroscopy, to be used within health-care to aid in diagnosing sinus related problems, e.g. sinusitis. The instrument provides information on the open/air filled sinus cavity size, the oxygen concentration in the cavity and thereby the ventilation status of the sinus. The technology is non-invasive and safe to use.

The improved diagnosing possibilities that come with this information can improve care, reduce cost of health care, and reduce the unnecessary prescribing of antibiotics which is related to the global threat of antibiotic resistance. The number of deaths related to antibiotic resistance was about 700 000 in 2015 and is expecting to grow to about 10 million persons/year in 2050 if nothing is changed.

The diagnostic tools used for suspected sinusitis today are either not useful enough and hard to interpret, or are painful and very time consuming since laboratory analysis of samples is needed. It would clearly be very valuable to have a better, simple tool for a quick evaluation of sinus related problems. Such a tool would help the physician making a correct diagnosis and better select which patients need further referral or treatment.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

The study has identified the market and the user needs, as well as the resources and financial requirements needed to commercialise the technology. We are convinced that the project is well worth pursuing. The business case is realistic and convincing, with a potential return of investment 3-4 years after product launch. In addition, it is likely that government subsidies in some countries will be implemented that support technologies that combat antibiotic resistance, making the business case even more compelling.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The project has evaluated the business case for the development of a device to be used for fast and reliable diagnostics of the sinus. The condition of sinusitis relates to about 20% of all prescribed antibiotics and by providing a tool for the diagnostics, the prescription of antibiotics can be reduced which would aid in the global struggle against antibiotic resistance. On the company scale, the development of this application in addition to the development of diagnostics of the lungs of premature babies, would not only grow GPX Medical but also connecting businesses like consultants, suppliers, distributors and other collaboration partners.

Company logotype